Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors

Abstract

Background Bronchial carcinoids are characterized by neuroendocrine differentiation and have distinct biological behavior, recurrence patterns, and prognosis compared with adenocarcinomas or squamous cell carcinomas. Because of their often indolent nature, it has been suggested that routine postoperative imaging surveillance may not be warranted in the majority of patients. This study aims to define the factors that predict disease-free survival (DFS) and recurrence after resection of these tumors, with the goal of identifying high-risk patients for whom image surveillance may be warranted.

Methods We conducted a retrospective review of a prospective database to identify patients with completely resected bronchial carcinoid tumors. Surgical procedure, histology, pathological stage, follow-up, tumor recurrence, and survival were assessed.

Results One hundred and forty-two patients were identified. Median age was 62 years and the majority was women (106). Surgical procedures included 20 wedge resections, 10 segmentectomies, 99 lobectomies, 3 bilobectomies, 2 pneumonectomies, 6 sleeve resections, and 2 bronchectomies. Pathologic stages included I (81%), II (10%), III (8%), and IV (1%). With a median follow-up of 31 months, there were seven recurrences. The 5- and 10-year overall survival rates were 92% and 75% and DFS rates were 88% and 72%, respectively. There were 34 patients with atypical carcinoids, and 6 (18%) developed recurrence, compared with 1 recurrence (1%) in the group of 108 patients with typical carcinoids (p = 0.0008). For atypical carcinoid tumors, the 5- and 10-year DFS rates were 72% and 32% versus 92% and 85% in typical carcinoid tumors (p = 0.001). Patients with more advanced tumor stage pT2–4 and pathologic N1/N2 nodal metastases had a significantly decreased 5- and 10-year DFS compared with those with early pT1 stage (p = 0.029) or those without nodal disease (p = 0.043). Multivariate Cox regression analyses showed advancing age (p = 0.001), atypical histology (p = 0.021), and advanced tumor stage (p = 0.047) were significant negative predictors for DFS.

Conclusion Long-term survival after resection of bronchial carcinoids is common, especially for patients with typical carcinoid tumors. DFS can be negatively influenced by atypical histology, advanced tumor, and nodal statuses. Efforts at postoperative image surveillance should target those patients with such high-risk factors.

Keywords

lung cancer - treatment - diagnosis - outcomes - carcinoid

• References

• 1 Ferguson MK, Landreneau RJ, Hazelrigg SR , et al. Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg 2000; 18 (2) 156-161
• 2 Filosso PL, Rena O, Donati G , et al. Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 2002; 123 (2) 303-309
• 3 Naalsund A, Rostad H, Strøm EH, Lund MB, Strand TE. Carcinoid lung tumors—incidence, treatment and outcomes: a population-based study. Eur J Cardiothorac Surg 2011; 39 (4) 565-569
• 4 Jacobson FL, Austin JH, Field JK , et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012; 144 (1) 25-32
• 5 Lou F, Sarkaria I, Pietanza C , et al. Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance. Ann Thorac Surg 2013; 96 (4) 1156-1162
• 6 Cao C, Yan TD, Kennedy C, Hendel N, Bannon PG, McCaughan BC. Bronchopulmonary carcinoid tumors: long-term outcomes after resection. Ann Thorac Surg 2011; 91 (2) 339-343
• 7 Aydin E, Yazici U, Gulgosteren M , et al. Long-term outcomes and prognostic factors of patients with surgically treated pulmonary carcinoid: our institutional experience with 104 patients. Eur J Cardiothorac Surg 2011; 39 (4) 549-554
• 8 Zhong CX, Yao F, Zhao H, Shi JX, Fan LM. Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years' experience with 131 patients. Chin Med J (Engl) 2012; 125 (17) 3022-3026
• 9 Travis WD, Rush W, Flieder DB , et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22 (8) 934-944
• 10 Cardillo G, Sera F, Di Martino M , et al. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 2004; 77 (5) 1781-1785
• 11 Jabbardarjani H, Masjedi M, Herth F. Successful treatment of endobronchial carcinoid using argon plasma coagulation. J Bronchology Interv Pulmonol 2009; 16 (3) 196-198
• 12 Bertino EM, Confer PD, Colonna JE, Ross P, Otterson GA. Pulmonary neuroendocrine/carcinoid tumors: a review article. Cancer 2009; 115 (19) 4434-4441
• 13 Neyman K, Sundset A, Naalsund A , et al. Endoscopic treatment of bronchial carcinoids in comparison to surgical resection: a retrospective study. J Bronchology Interv Pulmonol 2012; 19 (1) 29-34
• 14 Johnson R, Trocha S, McLawhorn M , et al. Histology, not lymph node involvement, predicts long-term survival in bronchopulmonary carcinoids. Am Surg 2011; 77 (12) 1669-1674
• 15 Bini A, Brandolini J, Cassanelli N , et al. Typical and atypical pulmonary carcinoids: our institutional experience. Interact Cardiovasc Thorac Surg 2008; 7 (3) 415-418
• 16 Fiala P, Petrásková K, Cernohorský S, Kinkor Z, Krepela E, Zatloukal P. Bronchial carcinoid tumors: long-term outcome after surgery. Neoplasma 2003; 50 (1) 60-65
• 17 Machuca TN, Cardoso PF, Camargo SM , et al. Surgical treatment of bronchial carcinoid tumors: a single-center experience. Lung Cancer 2010; 70 (2) 158-162
• 18 Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity. Am J Clin Oncol 2014; 37 (4) 350-355
• 19 Filosso P, Oliaro A, Ruffini E , et al. Outcome and prognostic factor in bronchial carcinoids. J Thorac Oncol 2013; 8: 1282-1288
• 20 Harpole Jr DH, Feldman JM, Buchanan S, Young WG, Wolfe WG. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg 1992; 54 (1) 50-54 , discussion 54–55
• 21 Kaplan B, Stevens CW, Allen P, Liao Z, Komaki R. Outcomes and patterns of failure in bronchial carcinoid tumors. Int J Radiat Oncol Biol Phys 2003; 55 (1) 125-131
• 22 Martini N, Zaman MB, Bains MS , et al. Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. J Thorac Cardiovasc Surg 1994; 107 (1) 1-6 , discussion 6–7
• 23 Divisi D, Crisci R. Carcinoid tumors of the lung and multimodal therapy. Thorac Cardiovasc Surg 2005; 53 (3) 168-172